{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:00:44Z","timestamp":1791172844566,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>The rate of progression of most interstitial lung diseases (ILD) is unpredictable. Fibrocytes are circulating bone marrow\u2013derived cells that have been implicated in the pathogenesis of lung fibrosis. Hermansky-Pudlak syndrome (HPS), a genetic cause of ILD in early adulthood, allows for study of biomarkers of ILD in a homogeneous population at near-certain risk of developing fibrotic lung disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To test the hypothesis that, in subjects with HPS, the number or phenotype of circulating fibrocytes predicts progression and outcome of ILD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We measured circulating fibrocyte counts and chemokine levels in a cohort of subjects with HPS and healthy control subjects and correlated the results to disease outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>In a cross-sectional analysis, peripheral blood fibrocyte concentrations were markedly elevated in a subset of subjects with HPS who had ILD but not subjects without lung disease or normal control subjects. The blood concentration of fibrocytes expressing the chemokine receptor CXCR4 correlated significantly with the plasma concentration of the CXCR4 ligand, CXCL12. In a longitudinal study, we found marked episodic elevations in circulating fibrocyte counts over a median follow-up period of 614 days. Elevations in both maximal values and final values of peripheral blood CXCR4+ fibrocyte concentration were strongly associated with death from ILD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CXCR4+ fibrocyte concentration may be useful as a biomarker for outcome of ILD in subjects with HPS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201407-1287oc","type":"journal-article","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T15:52:15Z","timestamp":1414425135000},"page":"1395-1401","source":"Crossref","is-referenced-by-count":36,"title":["Circulating Fibrocytes as Biomarker of Prognosis in Hermansky-Pudlak Syndrome"],"prefix":"10.1093","volume":"190","author":[{"given":"Aaron","family":"Trimble","sequence":"first","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette R.","family":"Gochuico","sequence":"additional","affiliation":[{"name":"Medical Genetics Branch and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Markello","sequence":"additional","affiliation":[{"name":"Medical Genetics Branch and"},{"name":"Office of the Clinical Director, National Human Genome Research Institute, Bethesda, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne","family":"Fischer","sequence":"additional","affiliation":[{"name":"Medical Genetics Branch and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Gahl","sequence":"additional","affiliation":[{"name":"Medical Genetics Branch and"},{"name":"Office of the Clinical Director, National Human Genome Research Institute, Bethesda, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae K.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngchul","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie D.","family":"Burdick","sequence":"additional","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Strieter","sequence":"additional","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borna","family":"Mehrad","sequence":"additional","affiliation":[{"name":"Department of Medicine and"},{"name":"The Carter Center for Immunology, University of Virginia, Charlottesville, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"key":"2026032100272371500_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","article-title":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias","volume":"165","author":"American Thoracic Society","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100272371500_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100272371500_bib3","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100272371500_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.biocel.2009.10.014","article-title":"Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis","volume":"42","author":"Keeley","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"2026032100272371500_bib5","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1186\/1755-1536-5-S1-S22","article-title":"Fibrocytes and the pathogenesis of diffuse parenchymal lung disease","volume":"5","author":"Mehrad","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"2026032100272371500_bib6","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.biocel.2009.02.020","article-title":"Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis","volume":"41","author":"Mehrad","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"2026032100272371500_bib7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0002-9440(10)62289-4","article-title":"CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury","volume":"166","author":"Moore","year":"2005","journal-title":"Am J Pathol"},{"key":"2026032100272371500_bib8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1172\/JCI200420997","article-title":"Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis","volume":"114","author":"Phillips","year":"2004","journal-title":"J Clin Invest"},{"key":"2026032100272371500_bib9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.biocel.2008.02.012","article-title":"Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis","volume":"40","author":"Andersson-Sj\u00f6land","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"2026032100272371500_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bbrc.2006.11.149","article-title":"Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease","volume":"353","author":"Mehrad","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"2026032100272371500_bib11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1164\/rccm.200810-1534OC","article-title":"Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis","volume":"179","author":"Moeller","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100272371500_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1542\/peds.2012-4003","article-title":"Hermansky-Pudlak syndrome: health care throughout life","volume":"132","author":"Seward","year":"2013","journal-title":"Pediatrics"},{"key":"2026032100272371500_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1378\/chest.117.1.129","article-title":"Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1","volume":"117","author":"Brantly","year":"2000","journal-title":"Chest"},{"key":"2026032100272371500_bib14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s004280000241","article-title":"Interstitial pneumonia in Hermansky-Pudlak syndrome: significance of florid foamy swelling\/degeneration (giant lamellar body degeneration) of type-2 pneumocytes","volume":"437","author":"Nakatani","year":"2000","journal-title":"Virchows Arch"},{"key":"2026032100272371500_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/13816819009020986","article-title":"Hermansky-Pudlak syndrome (HPS). An epidemiologic study","volume":"11","author":"Witkop","year":"1990","journal-title":"Ophthalmic Paediatr Genet"},{"key":"2026032100272371500_bib16","article-title":"Elevation in peripheral fibrocyte counts correlates with development of interstitial lung disease in patients with Hermansky-Pudlak syndrome. Presented at the American College of Chest Physicians Meeting. October 26\u201331, 2013, Chicago, IL","author":"Trimble"},{"key":"2026032100272371500_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ymgme.2011.02.003","article-title":"Pirfenidone for the treatment of Hermansky-Pudlak syndrome pulmonary fibrosis","volume":"103","author":"O\u2019Brien","year":"2011","journal-title":"Mol Genet Metab"},{"key":"2026032100272371500_bib18","doi-asserted-by":"crossref","first-page":"14098","DOI":"10.1073\/pnas.0511200103","article-title":"Secondary lymphoid tissue chemokine (SLC\/CCL21)\/CCR7 signaling regulates fibrocytes in renal fibrosis","volume":"103","author":"Sakai","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026032100272371500_bib19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0002-9343(90)90495-Y","article-title":"Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment","volume":"88","author":"Panos","year":"1990","journal-title":"Am J Med"},{"key":"2026032100272371500_bib20","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","article-title":"Acute exacerbations of idiopathic pulmonary fibrosis","volume":"176","author":"Collard","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100272371500_bib21","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1378\/chest.07-0299","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis","volume":"132","author":"Hyzy","year":"2007","journal-title":"Chest"},{"key":"2026032100272371500_bib22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1378\/chest.07-0323","article-title":"Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis","volume":"132","author":"Park","year":"2007","journal-title":"Chest"},{"key":"2026032100272371500_bib23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3858\/emm.2010.42.6.048","article-title":"Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis","volume":"42","author":"Song","year":"2010","journal-title":"Exp Mol Med"},{"key":"2026032100272371500_bib24","article-title":"Hermansky-Pudlak syndrome","author":"Gahl"},{"key":"2026032100272371500_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/mgme.1998.2729","article-title":"Hermansky-Pudlak syndrome: models for intracellular vesicle formation","volume":"65","author":"Shotelersuk","year":"1998","journal-title":"Mol Genet Metab"},{"key":"2026032100272371500_bib26","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1056\/NEJM199804303381803","article-title":"Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome)","volume":"338","author":"Gahl","year":"1998","journal-title":"N Engl J Med"},{"key":"2026032100272371500_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00439-003-0933-5","article-title":"Hermansky-Pudlak syndrome type 4 (HPS-4): clinical and molecular characteristics","volume":"113","author":"Anderson","year":"2003","journal-title":"Hum Genet"},{"key":"2026032100272371500_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2119\/molmed.2011.00198","article-title":"Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome type 2, an adaptor protein-3 complex disease","volume":"18","author":"Gochuico","year":"2012","journal-title":"Mol Med"},{"key":"2026032100272371500_bib29","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2214\/ajr.179.4.1790887","article-title":"Hermansky-Pudlak syndrome: radiography and CT of the chest compared with pulmonary function tests and genetic studies","volume":"179","author":"Avila","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"2026032100272371500_bib30","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1097\/HJH.0b013e32835639bb","article-title":"Elevated circulating fibrocyte levels in patients with hypertensive heart disease","volume":"30","author":"Keeley","year":"2012","journal-title":"J Hypertens"},{"key":"2026032100272371500_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1165\/rcmb.2005-0239OC","article-title":"The role of CCL12 in the recruitment of fibrocytes and lung fibrosis","volume":"35","author":"Moore","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026032100272371500_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ki.2013.84","article-title":"Fibrocytes develop outside the kidney but contribute to renal fibrosis in a mouse model","volume":"84","author":"Reich","year":"2013","journal-title":"Kidney Int"},{"key":"2026032100272371500_bib33","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1440-1843.2010.01862.x","article-title":"Fibrotic idiopathic interstitial pneumonias: mortality is linked to a decline in gas transfer","volume":"15","author":"Peelen","year":"2010","journal-title":"Respirology"},{"key":"2026032100272371500_bib34","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1164\/rccm.201105-0840OC","article-title":"Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference","volume":"184","author":"du Bois","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100272371500_bib35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1378\/chest.13-0844","article-title":"Predicting pulmonary fibrosis disease course from past trends in pulmonary function","volume":"145","author":"Schmidt","year":"2014","journal-title":"Chest"},{"key":"2026032100272371500_bib36","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","article-title":"A multidimensional index and staging system for idiopathic pulmonary fibrosis","volume":"156","author":"Ley","year":"2012","journal-title":"Ann Intern Med"},{"key":"2026032100272371500_bib37","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.13-1474","article-title":"Predicting survival across chronic interstitial lung disease: the ILD-GAP model","volume":"145","author":"Ryerson","year":"2014","journal-title":"Chest"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/190\/12\/1395\/67219429\/ajrccm_190_12_1395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/190\/12\/1395\/67219429\/ajrccm_190_12_1395.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:27:32Z","timestamp":1774067252000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/190\/12\/1395\/8505483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,1]]},"published-print":{"date-parts":[[2014,12,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201407-1287oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,12]]},"published":{"date-parts":[[2014,12,1]]}}}